Ziopharm Oncology Inc盘中异动大幅下跌5.49%报1.55美元

自选股智能写手2021-10-22

北京时间2021年10月22日22时05分，Ziopharm Oncology Inc（ZIOP.us）股票出现异动，股价急速下跌5.49%。截至发稿，该股报1.55美元/股，成交量26.3365万股，换手率0.12%，振幅4.88%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-22.67百万美元，每股收益-0.11美元，毛利-679000.00美元，市盈率-3.84倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2177141554?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/e9a9bab3010f8555516a533e81ce685f","is_english":false,"pubTime":"2021-10-22 22:05","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2177141554","market":"us","top_or_hot":-1,"title":"Ziopharm Oncology Inc盘中异动 大幅下跌5.49%报1.55美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2021年10月22日22时05分，Ziopharm Oncology Inc（ZIOP.us）股票出现异动，股价急速下跌5.49%。截至发稿，该股报1.55美元/股，成交量26.3365万股，换手率0.12%，振幅4.88%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-22.67百万美元，每股收益-0.11美元，毛利-679000.00美元，市盈率-3.84倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021102222050977f139eb&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ziopharm Oncology Inc盘中异动 大幅下跌5.49%报1.55美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZiopharm Oncology Inc盘中异动 大幅下跌5.49%报1.55美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-22 22:05 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021102222050977f139eb&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2021年10月22日22时05分，Ziopharm Oncology Inc（ZIOP.us）股票出现异动，股价急速下跌5.49%。截至发稿，该股报1.55美元/股，成交量26.3365万股，换手率0.12%，振幅4.88%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-22.67百万美元，每股收益-0.11美元，毛利-679000.00美元，市盈率-3.84倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021102222050977f139eb&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LHDX","symbol_name":"Lucira Health, Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021102222050977f139eb&s=b","article_id":"2177141554","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/e9a9bab3010f8555516a533e81ce685f"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021102222050977f139eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2177141554","pubTimestamp":1634911508,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2021年10月22日22时05分，Ziopharm Oncology Inc股票出现异动，股价急速下跌5.49%。截至发稿，该股报1.55美元/股，成交量26.3365万股，换手率0.12%，振幅4.88%。Ziopharm Oncology Inc股票所在的生物技术行业中，整体跌幅为1.46%。Ziopharm Oncology Inc公司简介：ZIOPHARM Oncology Inc是一家生物技术公司，致力于癌症治疗的获取，开发和商业化。Ziopharm与其合作伙伴Intrexon以及德克萨斯大学的合作者共同致力于基因治疗系统。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LHDX":"Lucira Health, Inc.","SANA":"Sana Biotechnology, Inc.","CGEM":"Cullinan Therapeutics","LABP":"Landos Biopharma, Inc.","APR":"Apria, Inc."},"translate_title":"Ziopharm Oncology Inc. fell 5.49 percent to $1.55 in intraday trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APR":1,"CGEM":1,"LABP":1,"LHDX":1,"SANA":1,"ZIOP":0.9},"content_text":"北京时间2021年10月22日22时05分，Ziopharm Oncology Inc（ZIOP.us）股票出现异动，股价急速下跌5.49%。截至发稿，该股报1.55美元/股，成交量26.3365万股，换手率0.12%，振幅4.88%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-22.67百万美元，每股收益-0.11美元，毛利-679000.00美元，市盈率-3.84倍。机构评级方面，在所有7家参与评级的机构中，43%的券商给予买入建议，57%的券商给予持有建议，无券商给予卖出建议。Ziopharm Oncology Inc股票所在的生物技术行业中，整体跌幅为1.46%。其相关个股中，Athira Pharma Inc、Context Therapeutics, Inc.、Nutriband Inc Warrant 2021- On Nutriband涨幅较大，Context Therapeutics, Inc.、Metacrine Inc、Progenity Inc较为活跃，换手率分别为44.02%、19.73%、13.28%，振幅较大的相关个股有Context Therapeutics, Inc.、Biofrontera Ag、Iveric Bio Inc，振幅分别为28.53%、26.16%、13.82%。Ziopharm Oncology Inc公司简介：ZIOPHARM Oncology Inc是一家生物技术公司，致力于癌症治疗的获取，开发和商业化。 该公司的临床前和临床流程重点在于使用细胞疗法治疗血液和实体肿瘤恶性肿瘤。 Ziopharm与其合作伙伴Intrexon以及德克萨斯大学的合作者共同致力于基因治疗系统。 为了投资其候选产品的发展，公司与美国和海外的许可合作伙伴进行合同安排。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2177141554"}

Ziopharm Oncology Inc盘中异动 大幅下跌5.49%报1.55美元

精彩评论

Ziopharm Oncology Inc盘中异动大幅下跌5.49%报1.55美元